These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2825248)

  • 21. Atherosclerosis precursors in Finnish children and adolescents--serum lipids, tracking of serum lipids, and preliminary results from cluster analyses of risk factors.
    Viikari J; Akerblom HK; Seppänen A; Marniemi J; Sarna S
    Prog Clin Biol Res; 1988; 255():81-7. PubMed ID: 3340648
    [No Abstract]   [Full Text] [Related]  

  • 22. [Blood lipid changes induced by chorionic gonadotropins in aged persons with arteriosclerosis].
    Salvioli GF; Neri M; Vecchi GP
    G Gerontol; 1971 Dec; 19(12):964-70. PubMed ID: 5147503
    [No Abstract]   [Full Text] [Related]  

  • 23. [Helicobacter pylori and cardiovascular pathology. Again the inflammatory hypothesis of arteriosclerosis].
    de Luis DA; Aller R; Boixeda de Miquel D
    An Med Interna; 2000 Mar; 17(3):115-7. PubMed ID: 10804632
    [No Abstract]   [Full Text] [Related]  

  • 24. [Structure and metabolism of high-density lipoproteins].
    Patsch JR
    Wien Klin Wochenschr; 1985 Apr; 97(8):374-6. PubMed ID: 2986365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the biochemical indicators of risk of atherosclerosis in children with simple obesity].
    Obuchowicz A; Szczepański Z
    Pediatr Pol; 1986 Jul; 61(7):409-14. PubMed ID: 3822604
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of cod liver oil on lipids, lipoproteins and platelet function in patients with atherosclerotic vasculopathy. 1. Atherosclerosis. Therapy. Basic concepts. 2. Clinical study. Conclusions].
    Gutiérrez Vallejo F; Gutiérrez Rosch F; Gutiérrez Rosch R; Rodríguez Fernández R; Ortiz Serrano A
    Angiologia; 1986; 38(1):17-31. PubMed ID: 3963517
    [No Abstract]   [Full Text] [Related]  

  • 27. Introduction. Lipids, inflammation and CVD--understanding the basics to break the atherosclerosis cycle.
    Barter P
    Int J Clin Pract Suppl; 2003 Oct; (137):2-4. PubMed ID: 14649696
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studies.
    Daugherty A; Roselaar SE
    Cardiovasc Res; 1995 Mar; 29(3):297-311. PubMed ID: 7781006
    [No Abstract]   [Full Text] [Related]  

  • 29. [Disorders of lipid metabolism as a risk factor for atherosclerosis in patients with chronic kidney insufficiency].
    Hertlová M; Sobotová D; Mocek J; Breinek P
    Vnitr Lek; 1986 Feb; 32(2):127-31. PubMed ID: 3962193
    [No Abstract]   [Full Text] [Related]  

  • 30. Dietary influences on lipids and lipoprotein levels in animals and atherosclerosis.
    Kritchevsky D
    Prog Biochem Pharmacol; 1983; 19():151-65. PubMed ID: 6298798
    [No Abstract]   [Full Text] [Related]  

  • 31. [Biochemical principles of early diagnosis of arteriosclerosis. I. behavior of blood lipids in arteriosclerosis].
    SZCZEKLIK E; ORLOWSKI M; JANIAKOWA A
    Pol Tyg Lek (Wars); 1958 May; 13(19):701-5. PubMed ID: 13567140
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on the lipid metabolism in experimental arteriosclerosis--relationship of hyperlipemia and plasma fatty acid compostion with development of atherosclerosis].
    Hao H
    Jpn Circ J; 1968 Dec; 32(12):1767-76. PubMed ID: 5756571
    [No Abstract]   [Full Text] [Related]  

  • 33. [Plasma lipids in normal subjects, and in patients with coronary disease and peripheral arteriopathy].
    Rusconi C; Gola E; Arosio G; Riva S; Frau G; Albertini A; Prandini BD; Spandrio L
    Minerva Med; 1973 Nov; 64(80):4209-16. PubMed ID: 4765428
    [No Abstract]   [Full Text] [Related]  

  • 34. [Lipoprotein metabolism (author's transl)].
    Wieland H; Seidel D
    Ther Umsch; 1980 Nov; 37(11):954-64. PubMed ID: 7455960
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of the high density lipoprotein-receptor cycle in macrophage-cholesterol metabolism.
    Schmitz G; Robenek H; Assmann G
    Klin Wochenschr; 1986 Oct; 64(19):979-85. PubMed ID: 3023738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fenofibrate and arteriosclerosis. The new developments of the last 5 years].
    Millán Núñez Cortés J; Alvarez-Sala Walther LA; de Oya Otero M
    Rev Clin Esp; 1995 Dec; 195(12):817-9. PubMed ID: 8599036
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dyslipidemia as a risk factor in atherogenesis].
    Panaitescu G; Fica V; Stănescu L; Serban M; Roşca L; Enache M
    Med Interna (Bucur); 1972 Apr; 24(4):423-40. PubMed ID: 5027788
    [No Abstract]   [Full Text] [Related]  

  • 38. [Biochemical problems of arteriosclerosis and vascular occlusion caused by arteriosclerosis].
    Kresse H
    Med Monatsschr; 1969 Apr; 23(4):166-71. PubMed ID: 5801516
    [No Abstract]   [Full Text] [Related]  

  • 39. [Lipids and atherosclerosis].
    González Santos P; De la Higuera Rojas J
    Rev Clin Esp; 1974 Mar; 132(5):387-98. PubMed ID: 4208680
    [No Abstract]   [Full Text] [Related]  

  • 40. [Impaired tolerance to the dietary fats and its contribution to atherothrombogenesis].
    Bubnova MG; Oganov RG
    Ter Arkh; 2004; 76(1):73-8. PubMed ID: 15108445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.